4Chen KS, Lai MK, Huang CC, et al. Urologic cancers in uremic patients[J]. Am J Kidney Dis,1995, 25(5) :694 -700.
5Weinberger SR,Dalmasso EA,Fung ET.Current achievenaents using Protein Chip Array technology.Curr Opin China Biol,2002,6(1):86-91.
6Sun Z,Fu X,Zhang L,et al.A protein chip system for parallel analysis of multi-tumor markers and its application in cancer detection.Anticancer Res,2004,24 (2C):1159-1165.
7Xiao WB,Liu YL.Elevation of serum and ascites cancer antigen 125 levels in patients with liver cirrhosis.J Gastroenterol Hepatol,2003,18(11):1315-1316.
8Sevinc A,Buyukberber S,Sari R,et al.Elevated serum CA125 levels in patients with nephrotic syndrome-induced ascites.Anticancer Res,2000,20(2B):1201-1203.
9Odagiri E,Jibiki K,Takeda M,et al.Effect of hernodialysis on the concentration of the seven tumor markers carcinoembryonic antigen,alpha-fetoprotein,squamous cell carcinoma-related antigen,neuron-specific enolase,CA125,CA199 and CA153 in uremic patients.Am J Nephrol,1991,11 (5):363.
10Lye WC,Tarnbyah P,Leong SO,et al.Serum tumor markers in patients on dialysis and kidney transplantation.Adv Petit Dial,1994,10:109-111.
38harathi Raja Rajaganapathy, Nirmal Jayabalan, Pradeep Tyagi, et al. Advances in therapeutic development for radiation cystitis [J].Lower Urinary Tract Symptoms,2014,6(1 ): 1 - 10.
4Huan-Chin Chang, Shou-Hung Tang, Feng-Pin Chuang, et al. Comparison between the use of percutaneous nephrostomy andinternal ureteral stenting in the management of long-term ureteral obstructions[J].Urological Science, 2012, 23(3):82-84.
